龍光(03380.HK)紀海鵬冀今年穩步回歸正常經營軌道
龍光集團(03380.HK)於上周末(27至28日)召開2024年度工作會議,以「堅定目標,奮進前行」為主題,龍光集團董事局主席紀海鵬指出,目前國內宏觀經濟和房地產行業已發生巨大變化,去年公司積極主動應對困難挑戰,取得階段性成果,期望今年全體員工繼續堅定目標、努力拼搏,全力落實各項目標任務,共度業界難關。
他表示,隨著房地產市場調整優化政策措施持續落地,經濟恢復預期向好。但政策效果顯現需時,房地產產業目前仍處於調整週期,因此要繼續做好度過困難時期的準備,今年集團將圍繞「促展期、保信用、穩經營、減成本」等八大工作,做好銷售及確保交付品質,確保完成全年目標任務,期望推動企業穩步回歸正常經營軌道。
Follow us
Find us on
Facebook,
Twitter ,
Instagram, and
YouTube or frequent updates on all things investing.Have a financial topic you would like to discuss? Head over to the
uSMART Community to share your thoughts and insights about the market! Click the picture below to download and explore uSMART app!

Disclaimers
uSmart Securities Limited (“uSmart”) is based on its internal research and public third party information in preparation of this article. Although uSmart uses its best endeavours to ensure the content of this article is accurate, uSmart does not guarantee the accuracy, timeliness or completeness of the information of this article and is not responsible for any views/opinions/comments in this article. Opinions, forecasts and estimations reflect uSmart’s assessment as of the date of this article and are subject to change. uSmart has no obligation to notify you or anyone of any such changes. You must make independent analysis and judgment on any matters involved in this article. uSmart and any directors, officers, employees or agents of uSmart will not be liable for any loss or damage suffered by any person in reliance on any representation or omission in the content of this article. The content of the article is for reference only and does not constitute any offer, solicitation, recommendation, opinion or guarantee of any securities, virtual assets, financial products or instruments. Regulatory authorities may restrict the trading of virtual asset-related ETFs to only investors who meet specified requirements. Any calculations or images in the article are for illustrative purposes only.
Investment involves risks and the value and income from securities may rise or fall. Past performance is not indicative of future performance. Please carefully consider your personal risk tolerance, and consult independent professional advice if necessary.